A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool
Recently, several clusters of hepatitis A have been observed among hemophiliacs linked to factor VIII concentrates treated for virus inactivation solely with the solvent/detergent (S/D) method, a procedure that does not affect nonenveloped viruses such as the hepatitis A virus (HAV). A new outbreak...
Gespeichert in:
Veröffentlicht in: | Journal of medical virology 1999-02, Vol.57 (2), p.91-99 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 99 |
---|---|
container_issue | 2 |
container_start_page | 91 |
container_title | Journal of medical virology |
container_volume | 57 |
creator | Chudy, Michael Budek, Irmhild Keller-Stanislawski, Brigitte McCaustland, Karen A. Neidhold, Sabine Robertson, Betty H. Nübling, C. Micha Seitz, Rainer Löwer, Johannes |
description | Recently, several clusters of hepatitis A have been observed among hemophiliacs linked to factor VIII concentrates treated for virus inactivation solely with the solvent/detergent (S/D) method, a procedure that does not affect nonenveloped viruses such as the hepatitis A virus (HAV). A new outbreak of hepatitis A in six hemophiliacs treated with the same lot of a factor VIII preparation occurred recently in Germany. The objective of the study was to clarify whether these diseases were caused by the administration of the S/D‐treated plasma product, rather than a community‐acquired infection. Polymerase chain reactions designed to detect HAV nucleic acid have been carried out in the implicated factor VIII lots, in the corresponding plasma pools, and in serum samples of four out of six infected individuals. The nucleic acid sequences were determined in samples that resulted in positive amplification products. HAV sequences were found in one of the two plasma pools used for manufacture of the incriminated product, in the incriminated lot itself, and in all recipient sera tested so far, although the latter were collected up to 7 weeks after the onset of jaundice. The sequences obtained were completely identical, revealing a unique HAV strain of genotype IA. This study provides conclusive evidence that hepatitis A can be transmitted by factor VIII concentrates treated solely by the S/D procedure for virus inactivation. This inactivation method is not effective against nonenveloped viruses. Since a number of hepatitis A transmission episodes have been described with such preparations during the past 10 years, their continued use seems to be questionable unless additional virus removal or inactivation steps are introduced to prevent the transmission of nonenveloped viruses. Molecular approaches again proved to be reliable tools for elucidating the chain of virus transmission. J. Med. Virol. 57:91–99, 1999. © 1999 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/(SICI)1096-9071(199902)57:2<91::AID-JMV1>3.0.CO;2-L |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69559137</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17148892</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4561-50076e12261bb8b267bc14cb432a8e24f6743769c37ff7765be880f3c26ea8e3</originalsourceid><addsrcrecordid>eNqFUk2P0zAQtRBoKYWfgOQDQruHFH8kdtxFSCXAblGXHlrBgcPI8TpaQxKHONWy_x6HVt0DCE4znnl68_SeETqnZEYJYa9ON8tieUaJEokikp5SpRRhZ5mcs9eKzueL5bvk49Vn-obPyKxYn7Nk9QBNjviHaEJoKhIhaPYYPQnhGyEkV4ydoBMVK1dkgr4ucGtvsal3YbA99hW-sZ0e3OACXmDXVtYMzrexi4vGdzeudtoEPPTa2Gs8eKyx8e2gG9fqIU66WodG4877-il6VOk62GeHOkXbD--3xWWyWl8si8UqMWkmaJIRIoWljAlalnnJhCwNTU2ZcqZzy9JKyJRLoQyXVSWlyEqb56TihgkbAXyKXu5pu97_2NkwQOOCsXWtW-t3AYTKMkW5_C-QSprmozFTtNkDTe9D6G0FXe8a3d8BJTBGAzBGA6PVMFoN-2ggk8BAUYAYDYzRAAcCxTpOV5H1-eH8rmzs9ZHzkEXcvzjsdTC6rnrdGhfuT4uUME7vxd262t79oezfwv6i6_c7siZ7Vhf_wc8jq-6_g5BcZvDl0wVsrxh7u1kxuOS_AFL3w4c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17148892</pqid></control><display><type>article</type><title>A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Chudy, Michael ; Budek, Irmhild ; Keller-Stanislawski, Brigitte ; McCaustland, Karen A. ; Neidhold, Sabine ; Robertson, Betty H. ; Nübling, C. Micha ; Seitz, Rainer ; Löwer, Johannes</creator><creatorcontrib>Chudy, Michael ; Budek, Irmhild ; Keller-Stanislawski, Brigitte ; McCaustland, Karen A. ; Neidhold, Sabine ; Robertson, Betty H. ; Nübling, C. Micha ; Seitz, Rainer ; Löwer, Johannes</creatorcontrib><description>Recently, several clusters of hepatitis A have been observed among hemophiliacs linked to factor VIII concentrates treated for virus inactivation solely with the solvent/detergent (S/D) method, a procedure that does not affect nonenveloped viruses such as the hepatitis A virus (HAV). A new outbreak of hepatitis A in six hemophiliacs treated with the same lot of a factor VIII preparation occurred recently in Germany. The objective of the study was to clarify whether these diseases were caused by the administration of the S/D‐treated plasma product, rather than a community‐acquired infection. Polymerase chain reactions designed to detect HAV nucleic acid have been carried out in the implicated factor VIII lots, in the corresponding plasma pools, and in serum samples of four out of six infected individuals. The nucleic acid sequences were determined in samples that resulted in positive amplification products. HAV sequences were found in one of the two plasma pools used for manufacture of the incriminated product, in the incriminated lot itself, and in all recipient sera tested so far, although the latter were collected up to 7 weeks after the onset of jaundice. The sequences obtained were completely identical, revealing a unique HAV strain of genotype IA. This study provides conclusive evidence that hepatitis A can be transmitted by factor VIII concentrates treated solely by the S/D procedure for virus inactivation. This inactivation method is not effective against nonenveloped viruses. Since a number of hepatitis A transmission episodes have been described with such preparations during the past 10 years, their continued use seems to be questionable unless additional virus removal or inactivation steps are introduced to prevent the transmission of nonenveloped viruses. Molecular approaches again proved to be reliable tools for elucidating the chain of virus transmission. J. Med. Virol. 57:91–99, 1999. © 1999 Wiley‐Liss, Inc.</description><identifier>ISSN: 0146-6615</identifier><identifier>EISSN: 1096-9071</identifier><identifier>DOI: 10.1002/(SICI)1096-9071(199902)57:2<91::AID-JMV1>3.0.CO;2-L</identifier><identifier>PMID: 9892390</identifier><identifier>CODEN: JMVIDB</identifier><language>eng</language><publisher>New York: John Wiley & Sons, Inc</publisher><subject>Adult ; Biological and medical sciences ; Blood-Borne Pathogens - isolation & purification ; Cluster Analysis ; Disease Outbreaks ; Factor VIII - adverse effects ; Genotype ; Germany ; HAV transmission ; Hemophilia A - complications ; Hemophilia A - virology ; Hepatitis A - complications ; Hepatitis A - epidemiology ; Hepatitis A - etiology ; Hepatitis A - virology ; Hepatitis A virus ; Hepatovirus - genetics ; Hepatovirus - isolation & purification ; Human viral diseases ; Humans ; Infectious diseases ; Medical sciences ; Middle Aged ; nucleic acid sequence ; Phylogeny ; Reverse Transcriptase Polymerase Chain Reaction ; RNA, Viral - blood ; S/D-treated factor VIII ; Sequence Analysis, DNA ; Sequence Homology, Nucleic Acid ; Space life sciences ; Viral diseases ; Viral hepatitis ; Viral Proteins - genetics ; Viral Structural Proteins - genetics ; von Willebrand Diseases - complications ; von Willebrand Diseases - virology</subject><ispartof>Journal of medical virology, 1999-02, Vol.57 (2), p.91-99</ispartof><rights>Copyright © 1999 Wiley‐Liss, Inc.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4561-50076e12261bb8b267bc14cb432a8e24f6743769c37ff7765be880f3c26ea8e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291096-9071%28199902%2957%3A2%3C91%3A%3AAID-JMV1%3E3.0.CO%3B2-L$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291096-9071%28199902%2957%3A2%3C91%3A%3AAID-JMV1%3E3.0.CO%3B2-L$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27929,27930,45579,45580</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1640231$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9892390$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chudy, Michael</creatorcontrib><creatorcontrib>Budek, Irmhild</creatorcontrib><creatorcontrib>Keller-Stanislawski, Brigitte</creatorcontrib><creatorcontrib>McCaustland, Karen A.</creatorcontrib><creatorcontrib>Neidhold, Sabine</creatorcontrib><creatorcontrib>Robertson, Betty H.</creatorcontrib><creatorcontrib>Nübling, C. Micha</creatorcontrib><creatorcontrib>Seitz, Rainer</creatorcontrib><creatorcontrib>Löwer, Johannes</creatorcontrib><title>A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool</title><title>Journal of medical virology</title><addtitle>J. Med. Virol</addtitle><description>Recently, several clusters of hepatitis A have been observed among hemophiliacs linked to factor VIII concentrates treated for virus inactivation solely with the solvent/detergent (S/D) method, a procedure that does not affect nonenveloped viruses such as the hepatitis A virus (HAV). A new outbreak of hepatitis A in six hemophiliacs treated with the same lot of a factor VIII preparation occurred recently in Germany. The objective of the study was to clarify whether these diseases were caused by the administration of the S/D‐treated plasma product, rather than a community‐acquired infection. Polymerase chain reactions designed to detect HAV nucleic acid have been carried out in the implicated factor VIII lots, in the corresponding plasma pools, and in serum samples of four out of six infected individuals. The nucleic acid sequences were determined in samples that resulted in positive amplification products. HAV sequences were found in one of the two plasma pools used for manufacture of the incriminated product, in the incriminated lot itself, and in all recipient sera tested so far, although the latter were collected up to 7 weeks after the onset of jaundice. The sequences obtained were completely identical, revealing a unique HAV strain of genotype IA. This study provides conclusive evidence that hepatitis A can be transmitted by factor VIII concentrates treated solely by the S/D procedure for virus inactivation. This inactivation method is not effective against nonenveloped viruses. Since a number of hepatitis A transmission episodes have been described with such preparations during the past 10 years, their continued use seems to be questionable unless additional virus removal or inactivation steps are introduced to prevent the transmission of nonenveloped viruses. Molecular approaches again proved to be reliable tools for elucidating the chain of virus transmission. J. Med. Virol. 57:91–99, 1999. © 1999 Wiley‐Liss, Inc.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Blood-Borne Pathogens - isolation & purification</subject><subject>Cluster Analysis</subject><subject>Disease Outbreaks</subject><subject>Factor VIII - adverse effects</subject><subject>Genotype</subject><subject>Germany</subject><subject>HAV transmission</subject><subject>Hemophilia A - complications</subject><subject>Hemophilia A - virology</subject><subject>Hepatitis A - complications</subject><subject>Hepatitis A - epidemiology</subject><subject>Hepatitis A - etiology</subject><subject>Hepatitis A - virology</subject><subject>Hepatitis A virus</subject><subject>Hepatovirus - genetics</subject><subject>Hepatovirus - isolation & purification</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>nucleic acid sequence</subject><subject>Phylogeny</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA, Viral - blood</subject><subject>S/D-treated factor VIII</subject><subject>Sequence Analysis, DNA</subject><subject>Sequence Homology, Nucleic Acid</subject><subject>Space life sciences</subject><subject>Viral diseases</subject><subject>Viral hepatitis</subject><subject>Viral Proteins - genetics</subject><subject>Viral Structural Proteins - genetics</subject><subject>von Willebrand Diseases - complications</subject><subject>von Willebrand Diseases - virology</subject><issn>0146-6615</issn><issn>1096-9071</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUk2P0zAQtRBoKYWfgOQDQruHFH8kdtxFSCXAblGXHlrBgcPI8TpaQxKHONWy_x6HVt0DCE4znnl68_SeETqnZEYJYa9ON8tieUaJEokikp5SpRRhZ5mcs9eKzueL5bvk49Vn-obPyKxYn7Nk9QBNjviHaEJoKhIhaPYYPQnhGyEkV4ydoBMVK1dkgr4ucGtvsal3YbA99hW-sZ0e3OACXmDXVtYMzrexi4vGdzeudtoEPPTa2Gs8eKyx8e2gG9fqIU66WodG4877-il6VOk62GeHOkXbD--3xWWyWl8si8UqMWkmaJIRIoWljAlalnnJhCwNTU2ZcqZzy9JKyJRLoQyXVSWlyEqb56TihgkbAXyKXu5pu97_2NkwQOOCsXWtW-t3AYTKMkW5_C-QSprmozFTtNkDTe9D6G0FXe8a3d8BJTBGAzBGA6PVMFoN-2ggk8BAUYAYDYzRAAcCxTpOV5H1-eH8rmzs9ZHzkEXcvzjsdTC6rnrdGhfuT4uUME7vxd262t79oezfwv6i6_c7siZ7Vhf_wc8jq-6_g5BcZvDl0wVsrxh7u1kxuOS_AFL3w4c</recordid><startdate>199902</startdate><enddate>199902</enddate><creator>Chudy, Michael</creator><creator>Budek, Irmhild</creator><creator>Keller-Stanislawski, Brigitte</creator><creator>McCaustland, Karen A.</creator><creator>Neidhold, Sabine</creator><creator>Robertson, Betty H.</creator><creator>Nübling, C. Micha</creator><creator>Seitz, Rainer</creator><creator>Löwer, Johannes</creator><general>John Wiley & Sons, Inc</general><general>Wiley-Liss</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7U2</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>199902</creationdate><title>A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool</title><author>Chudy, Michael ; Budek, Irmhild ; Keller-Stanislawski, Brigitte ; McCaustland, Karen A. ; Neidhold, Sabine ; Robertson, Betty H. ; Nübling, C. Micha ; Seitz, Rainer ; Löwer, Johannes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4561-50076e12261bb8b267bc14cb432a8e24f6743769c37ff7765be880f3c26ea8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Blood-Borne Pathogens - isolation & purification</topic><topic>Cluster Analysis</topic><topic>Disease Outbreaks</topic><topic>Factor VIII - adverse effects</topic><topic>Genotype</topic><topic>Germany</topic><topic>HAV transmission</topic><topic>Hemophilia A - complications</topic><topic>Hemophilia A - virology</topic><topic>Hepatitis A - complications</topic><topic>Hepatitis A - epidemiology</topic><topic>Hepatitis A - etiology</topic><topic>Hepatitis A - virology</topic><topic>Hepatitis A virus</topic><topic>Hepatovirus - genetics</topic><topic>Hepatovirus - isolation & purification</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>nucleic acid sequence</topic><topic>Phylogeny</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA, Viral - blood</topic><topic>S/D-treated factor VIII</topic><topic>Sequence Analysis, DNA</topic><topic>Sequence Homology, Nucleic Acid</topic><topic>Space life sciences</topic><topic>Viral diseases</topic><topic>Viral hepatitis</topic><topic>Viral Proteins - genetics</topic><topic>Viral Structural Proteins - genetics</topic><topic>von Willebrand Diseases - complications</topic><topic>von Willebrand Diseases - virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chudy, Michael</creatorcontrib><creatorcontrib>Budek, Irmhild</creatorcontrib><creatorcontrib>Keller-Stanislawski, Brigitte</creatorcontrib><creatorcontrib>McCaustland, Karen A.</creatorcontrib><creatorcontrib>Neidhold, Sabine</creatorcontrib><creatorcontrib>Robertson, Betty H.</creatorcontrib><creatorcontrib>Nübling, C. Micha</creatorcontrib><creatorcontrib>Seitz, Rainer</creatorcontrib><creatorcontrib>Löwer, Johannes</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Safety Science and Risk</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medical virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chudy, Michael</au><au>Budek, Irmhild</au><au>Keller-Stanislawski, Brigitte</au><au>McCaustland, Karen A.</au><au>Neidhold, Sabine</au><au>Robertson, Betty H.</au><au>Nübling, C. Micha</au><au>Seitz, Rainer</au><au>Löwer, Johannes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool</atitle><jtitle>Journal of medical virology</jtitle><addtitle>J. Med. Virol</addtitle><date>1999-02</date><risdate>1999</risdate><volume>57</volume><issue>2</issue><spage>91</spage><epage>99</epage><pages>91-99</pages><issn>0146-6615</issn><eissn>1096-9071</eissn><coden>JMVIDB</coden><abstract>Recently, several clusters of hepatitis A have been observed among hemophiliacs linked to factor VIII concentrates treated for virus inactivation solely with the solvent/detergent (S/D) method, a procedure that does not affect nonenveloped viruses such as the hepatitis A virus (HAV). A new outbreak of hepatitis A in six hemophiliacs treated with the same lot of a factor VIII preparation occurred recently in Germany. The objective of the study was to clarify whether these diseases were caused by the administration of the S/D‐treated plasma product, rather than a community‐acquired infection. Polymerase chain reactions designed to detect HAV nucleic acid have been carried out in the implicated factor VIII lots, in the corresponding plasma pools, and in serum samples of four out of six infected individuals. The nucleic acid sequences were determined in samples that resulted in positive amplification products. HAV sequences were found in one of the two plasma pools used for manufacture of the incriminated product, in the incriminated lot itself, and in all recipient sera tested so far, although the latter were collected up to 7 weeks after the onset of jaundice. The sequences obtained were completely identical, revealing a unique HAV strain of genotype IA. This study provides conclusive evidence that hepatitis A can be transmitted by factor VIII concentrates treated solely by the S/D procedure for virus inactivation. This inactivation method is not effective against nonenveloped viruses. Since a number of hepatitis A transmission episodes have been described with such preparations during the past 10 years, their continued use seems to be questionable unless additional virus removal or inactivation steps are introduced to prevent the transmission of nonenveloped viruses. Molecular approaches again proved to be reliable tools for elucidating the chain of virus transmission. J. Med. Virol. 57:91–99, 1999. © 1999 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley & Sons, Inc</pub><pmid>9892390</pmid><doi>10.1002/(SICI)1096-9071(199902)57:2<91::AID-JMV1>3.0.CO;2-L</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0146-6615 |
ispartof | Journal of medical virology, 1999-02, Vol.57 (2), p.91-99 |
issn | 0146-6615 1096-9071 |
language | eng |
recordid | cdi_proquest_miscellaneous_69559137 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Adult Biological and medical sciences Blood-Borne Pathogens - isolation & purification Cluster Analysis Disease Outbreaks Factor VIII - adverse effects Genotype Germany HAV transmission Hemophilia A - complications Hemophilia A - virology Hepatitis A - complications Hepatitis A - epidemiology Hepatitis A - etiology Hepatitis A - virology Hepatitis A virus Hepatovirus - genetics Hepatovirus - isolation & purification Human viral diseases Humans Infectious diseases Medical sciences Middle Aged nucleic acid sequence Phylogeny Reverse Transcriptase Polymerase Chain Reaction RNA, Viral - blood S/D-treated factor VIII Sequence Analysis, DNA Sequence Homology, Nucleic Acid Space life sciences Viral diseases Viral hepatitis Viral Proteins - genetics Viral Structural Proteins - genetics von Willebrand Diseases - complications von Willebrand Diseases - virology |
title | A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T12%3A43%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20new%20cluster%20of%20hepatitis%20A%20infection%20in%20hemophiliacs%20traced%20to%20a%20contaminated%20plasma%20pool&rft.jtitle=Journal%20of%20medical%20virology&rft.au=Chudy,%20Michael&rft.date=1999-02&rft.volume=57&rft.issue=2&rft.spage=91&rft.epage=99&rft.pages=91-99&rft.issn=0146-6615&rft.eissn=1096-9071&rft.coden=JMVIDB&rft_id=info:doi/10.1002/(SICI)1096-9071(199902)57:2%3C91::AID-JMV1%3E3.0.CO;2-L&rft_dat=%3Cproquest_cross%3E17148892%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17148892&rft_id=info:pmid/9892390&rfr_iscdi=true |